Palisade Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
55,284
-240
-0.4% -$13K 0.36% 68
2026
Q1
$2.9M Hold
55,524
0.29% 74
2025
Q4
$3.27M Sell
55,524
-25
-0% -$1.52K 0.32% 70
2025
Q3
$3.09M Hold
55,549
0.29% 72
2025
Q2
$2.86M Sell
55,549
-800
-1% -$40.2K 0.28% 73
2025
Q1
$3.3M Hold
56,349
0.34% 66
2024
Q4
$4.06M Sell
56,349
-260
-0.5% -$19.1K 0.41% 57
2024
Q3
$4.52M Buy
56,609
+1,160
+2% +$87.2K 0.44% 53
2024
Q2
$3.97M Sell
55,449
-85
-0.2% -$6.26K 0.41% 60
2024
Q1
$3.91M Buy
55,534
+9,275
+20% +$664K 0.38% 63
2023
Q4
$3.57M Sell
46,259
-160
-0.3% -$10.5K 0.39% 62
2023
Q3
$3.16M Sell
46,419
-9,185
-17% -$726K 0.38% 63
2023
Q2
$4.54M Hold
55,604
0.53% 57
2023
Q1
$4.13M Sell
55,604
-272
-0.5% -$21K 0.51% 58
2022
Q4
$4.63M Sell
55,876
-908
-2% -$72.1K 0.53% 56
2022
Q3
$4.03M Sell
56,784
-80
-0.1% -$6.91K 0.55% 56
2022
Q2
$4.93M Sell
56,864
-80
-0.1% -$7.5K 0.63% 52
2022
Q1
$6.17M Sell
56,944
-400
-0.7% -$41.3K 0.71% 48
2021
Q4
$7.42M Sell
57,344
-312
-0.5% -$38.2K 0.83% 45
2021
Q3
$6.99M Sell
57,656
-560
-1% -$68.2K 0.85% 45
2021
Q2
$6.55M Sell
58,216
-80
-0.1% -$8.42K 0.77% 46
2021
Q1
$5.57M Sell
58,296
-140
-0.2% -$12.8K 0.72% 49
2020
Q4
$4.64M Hold
58,436
0.63% 53
2020
Q3
$3.62M Hold
58,436
0.55% 57
2020
Q2
$3.86M Sell
58,436
-160
-0.3% -$9.58K 0.62% 54
2020
Q1
$2.78M Hold
58,596
0.51% 59
2019
Q4
$3.22M Hold
58,596
0.47% 61
2019
Q3
$2.87M Sell
58,596
-3,800
-6% -$191K 0.44% 66
2019
Q2
$3.25M Hold
62,396
0.51% 61
2019
Q1
$3.1M Buy
62,396
+2,300
+4% +$104K 0.49% 62
2018
Q4
$2.17M Sell
60,096
-1,100
-2% -$45.9K 0.32% 66
2018
Q3
$3.12M Sell
61,196
-3,096
-5% -$137K 0.41% 60
2018
Q2
$2.38M Buy
64,292
+560
+0.9% +$21.4K 0.34% 64
2018
Q1
$2.41M Hold
63,732
0.36% 61
2017
Q4
$2.06M Sell
63,732
-6,000
-9% -$191K 0.33% 67
2017
Q3
$2.11M Sell
69,732
-800
-1% -$23.7K 0.38% 60
2017
Q2
$2.07M Hold
70,532
0.41% 58
2017
Q1
$1.79M Sell
70,532
-1,200
-2% -$31K 0.33% 62
2016
Q4
$1.84M Hold
71,732
0.35% 57
2016
Q3
$1.96M Hold
71,732
0.37% 55
2016
Q2
$2.02M Sell
71,732
-800
-1% -$20.6K 0.38% 58
2016
Q1
$1.71M Buy
72,532
+6,800
+10% +$150K 0.33% 63
2015
Q4
$1.48M Hold
65,732
0.32% 63
2015
Q3
$1.52M Buy
65,732
+600
+0.9% +$15K 0.34% 68
2015
Q2
$1.6M Sell
65,132
-140
-0.2% -$3.5K 0.32% 70
2015
Q1
$1.64M Buy
65,272
+232
+0.4% +$5.52K 0.32% 68
2014
Q4
$1.5M Hold
65,040
0.3% 70
2014
Q3
$1.52M Hold
65,040
0.31% 66
2014
Q2
$1.5M Sell
65,040
-1,600
-2% -$35.4K 0.32% 66
2014
Q1
$1.42M Hold
66,640
0.31% 68
2013
Q4
$1.58M Buy
66,640
+1,200
+2% +$26K 0.36% 61
2013
Q3
$1.31M Sell
65,440
-2,800
-4% -$53.1K 0.33% 64
2013
Q2
$1.18M Buy
+68,240
New +$1.13M 0.3% 69

Other funds holding TECH

Palisade Asset Management's TECH Position: Q2 2026 in Review

Palisade Asset Management reduced its Bio-Techne (TECH) stake by 0.43% in Q2 2026, selling an estimated $13K and leaving 55,284 shares worth $3.91M. The position accounts for 0.36% of the portfolio, ranked #68.

Palisade Asset Management first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.42M in Q4 2021. 104 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Palisade Asset Management held 55,284 shares of Bio-Techne worth $3.91M as of Q2 2026.
  • Palisade Asset Management sold 240 Bio-Techne shares in Q2 2026, an estimated $13K.
  • Bio-Techne made up 0.36% of Palisade Asset Management's portfolio in Q2 2026, its #68 holding.
  • Palisade Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's Bio-Techne position peaked at $7.42M in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.